Found 14 matching trials
Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women
PHASE4Vulvovaginal atrophy (VVA) is a condition characterized by vaginal dryness,...
Location
Karolinska University Hospital
Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia
PHASE4Open label study at a single research center. Subjects meeting inclusion an...
Location
San Diego Sexual Medicine
Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors
PHASE2The purpose of this research is to gather information on the safety and eff...
Location
University of Arkansas for Medical Sciences
Topical DHEA Against Vaginal Atrophy
PHASE3The purpose of this study is to determine the dose-response of vaginal muco...
Location
EndoCeutics site # 05
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
PHASE3The primary objective is to confirm the efficacy of intravaginal prasterone...
Location
Endoceutics site # 106
Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy
PHASE3The purpose of this Phase III trial is to evaluate the efficacy of intravag...
Location
EndoCeutics site # 39
DHEA Against Vaginal Atrophy - Safety Study of 12 Months
PHASE3The purpose of this Phase III trial is to assess the long-term safety of in...
Location
EndoCeutics site # 39
DHEA Against Vaginal Atrophy - 3-Month Efficacy Study
PHASE3The purpose of this Phase III trial is to confirm the efficacy of intravagi...
Location
EndoCeutics site # 39
DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy
PHASE1The purpose of the study is to evaluate the systemic bioavailability of DHE...
Location
Clinique des traitements hormonaux CHUL Research Center
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
PHASE3The primary objective is to confirm the efficacy of intravaginal prasterone...
Location
Endoceutics site # 106